Whole-body MRI scans have risen to prominence for their alleged ability to catch many health conditions early. But are they ...

Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

The Stakes Couldn't Be HigherThis is more than a marijuana case. It's a constitutional case. It's a test of whether the DEA is still accountable to the courts, to the people, and to the law."If the ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...